Oracle’s industry-leading consultants specialize in helping define, substantiate, and communicate to key stakeholders the true value of therapeutic products. With comprehensive site-based and direct-to-patient evidence generation capabilities, and extensive proprietary databases, we help mitigate risk and support product success.
Observational studies offer real-world insights into how therapies are prescribed and their short-, medium-, and long-term effect on outcomes. Understand disease occurrence, identify risk factors, learn about prescription patterns, monitor long-term effectiveness, and redefine your approach to clinical testing moving forward. With Oracle, you can gain access to industry-leading clinical and real-world researchers to help demonstrate the precise value of your therapeutics to stakeholders.
We draw from significant experience in conducting clinical trials, late-phase studies, and post-marketing non-interventional studies, which are increasingly important for assessing drug safety post-authorization, product effectiveness, and utilization patterns under real-world conditions. Risk management forms an integral part of our holistic real-world evidence solutions, helping you to be well-prepared to safeguard your medicinal products and devices among demanding healthcare stakeholders.
Our expansive clinical network provides on-the-ground local support across the globe. Our clinical and real-world research team manages this network, coordinating study design, site selection, training, regulatory and legal compliance, quality management, site management, data collection and management, pharmacovigilance and drug safety, and analysis and reporting.
Through our streamlined web-based EDC systems, we offer innovative, real-time study data visualization and analytics, as well as powerful site-specific and complete study reporting capabilities.
The Oracle Life Sciences Clinical One platform goes beyond electronic data capture, allowing you to collect and combine data sets from any source to draw valuable clinical insights.
We offer comprehensive contract research organization (CRO) services such as protocol design and study reports, backed by legal and regulatory expertise and a rich legacy of global research that spans more than 2,000 scientific publications, including articles, posters and abstracts.
Our team has broad expertise across key indication areas including ophthalmology, dermatology, inflammation, cardiovascular issues, respiratory issues, neurology, and chronic diseases, with a particular focus on oncology and rare diseases.
We specialize in world-class evidence generation, with comprehensive clinical data collection capabilities and proprietary databases spanning the globe. Whether your need originates from market access, regulatory or medical affairs, pharmacovigilance, or health economics and outcomes research, we can help you generate real-world evidence to manage risk and support the success of your product through its lifecycle.
In addition to custom designed non-interventional studies, we provide access to a large breadth of proprietary patient sources including the Oracle Life Sciences National Health and Wellness Survey, electronic health records (EHR), and claims databases for the real-world evidence required to meet your goals.
Oracle EHR Real-World Data is our national, anonymized real-world data set for conducting observational studies and post-market surveillance. With access to more than 108 million patient records across multiple venues of care, we can analyze patient data and map patient journeys to uncover insights and produce evidence across various clinical metrics.
與 Oracle 團隊成員討論我們的生命科學解決方案。
聆聽來自製藥、生物技術和 CRO 的科學家、臨床醫生及業界領袖的分享,瞭解他們如何推動生命科學和健康領域的創新。
瞭解技術支援聯絡人和資源。